On Friday, Lexaria Bioscience Corp (NASDAQ: LEXX) was -14.96% drop from the session before settling in for the closing price of $0.69. A 52-week range for LEXX has been $0.66 – $2.43.
During the last 5-year period, the sales growth of Healthcare Sector giant was 14.15%. When this article was written, the company’s average yearly earnings per share was at 47.69%. With a float of $23.39 million, this company’s outstanding shares have now reached $24.89 million.
Lexaria Bioscience Corp (LEXX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Lexaria Bioscience Corp stocks. The insider ownership of Lexaria Bioscience Corp is 6.00%, while institutional ownership is 6.90%. The most recent insider transaction that took place on Jul 29 ’25, was worth 14,375. In this transaction Director of this company bought 15,600 shares at a rate of $0.92, taking the stock ownership to the 270,012 shares. Before that another transaction happened on Jul 30 ’25, when Company’s Director bought 11,900 for $0.91, making the entire transaction worth $10,866. This insider now owns 281,912 shares in total.
Lexaria Bioscience Corp (LEXX) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 11/30/2024, it has been observed that the corporation posted -0.16 earnings per share (EPS) during the time that was less than consensus figure (set at -0.12) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.69% per share during the next fiscal year.
Lexaria Bioscience Corp (NASDAQ: LEXX) Trading Performance Indicators
You can see what Lexaria Bioscience Corp (LEXX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66 and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of Lexaria Bioscience Corp (LEXX)
Looking closely at Lexaria Bioscience Corp (NASDAQ: LEXX), its last 5-days average volume was 1.02 million, which is a jump from its year-to-date volume of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 4.85%.
During the past 100 days, Lexaria Bioscience Corp’s (LEXX) raw stochastic average was set at 9.59%, which indicates a significant decrease from 10.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1152 in the past 14 days, which was higher than the 0.0924 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0048, while its 200-day Moving Average is $1.0805. However, in the short run, Lexaria Bioscience Corp’s stock first resistance to watch stands at $0.6743. Second resistance stands at $0.7659. The third major resistance level sits at $0.8631. If the price goes on to break the first support level at $0.4855, it is likely to go to the next support level at $0.3883. Now, if the price goes above the second support level, the third support stands at $0.2967.
Lexaria Bioscience Corp (NASDAQ: LEXX) Key Stats
There are 22,226K outstanding shares of the company, which has a market capitalization of 14.50 million. As of now, sales total 710 K while income totals -11,900 K. Its latest quarter income was 170 K while its last quarter net income were -2,700 K.
